Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

American Oncology Network, Inc.

AONCNASDAQ
Healthcare
Medical - Care Facilities
$12.00
$0.00(0.00%)
U.S. Market opens in 1h 56m

American Oncology Network, Inc. (AONC) Stock Forecast & Price Predictions

Get the latest American Oncology Network, Inc. (AONC) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.

Model Information

The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Monthly Forecast

Predicted Price$11.93
Change↓ $-0.07 (-0.58%)

Quarterly Forecast

Predicted Price$13.80
Change↑ $1.80 (15.00%)

Yearly Forecast

Predicted Price$17.88
Change↑ $5.88 (49.02%)

3 Years Forecast

Predicted Price$30.86
Change↑ $18.86 (157.17%)

5 Years Forecast

Predicted Price$43.77
Change↑ $31.77 (264.75%)

7 Years Forecast

Predicted Price$56.98
Change↑ $44.98 (374.80%)

American Oncology Network, Inc. Stock Forecast Summary

American Oncology Network, Inc. (AONC) stock is currently priced at $12.00. Based on Meyka AI predictions, the short-term outlook is bearish, with momentum pointing higher. The 1-month projection suggests a move toward $11.93.

In the long term, AONC shows a bullish trend. The 2027 forecast points to $17.88 (49.02% change), while the 2031 forecast suggests $43.77 (264.75% change). Looking 7 years ahead, projections estimate the stock could trade near $56.98, a 374.80% change from today’s price.

Overall Sentiment

Neutral

Short-Term Outlook

Bearish

Long-Term Outlook

Bullish

This mix indicates that American Oncology Network, Inc. stock is expected to rise steadily over the coming years.

American Oncology Network, Inc. yearly Price Forecast Chart

Explore the yearly forecast chart for AONC, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate American Oncology Network, Inc. over different timeframes.

No forecast data available

No prediction data found for this time period.

empty-state-iconForecasting data is not available for AONCForecasting details for AONC are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

American Oncology Network, Inc. Stock Forecast 2026

The forecast for American Oncology Network, Inc. (AONC) in 2026 suggests a price of $17.88, representing a 49.02% move from today’s price.

Average Target: $17.88

Market Outlook: bullish based on current trend indicators.

Key Drivers in 2026:
  • Earnings growth projections.
  • Competitive performance in the Healthcare.
  • Macroeconomic factors such as interest rates and inflation.

American Oncology Network, Inc. Stock Forecast 2030

By 2030, Meyka AI projects AONC could trade near $43.77, showing a potential 264.75% compared to current levels.

Average Target: $43.77

Market Outlook: bullish.

What could influence the 2030 forecast:
  • Technological innovation and product cycles.
  • Expansion into global markets.
  • Long-term investor sentiment toward American Oncology Network, Inc..

American Oncology Network, Inc. 7-Year Stock Forecast (20322033)

Looking 7 years ahead, the long-term forecast for AONC points to a price around $56.98, which is a projected 374.80% move from today’s level.

Average Target: $56.98

Outlook: bullish, depending on macroeconomic conditions and sector growth.

Long-Term Drivers:
  • Global economic expansion or contraction.
  • Regulatory and policy environment.
  • American Oncology Network, Inc.’s ability to maintain market leadership.

Frequently Asked Questions